News

Primo Biotechnology Co., Ltd. ("Primo") proudly announces that its Taoyuan pharmaceutical facility has successfully passed ...
As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...
Hosted at nonprofit incubator and accelerator Winston Starts, The Founders’ Journey focused on venture-backed biotechnology ...
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. Renowned for its blockbuster drugs like Lipitor ...
YJ Biotechnology has been transforming regenerative medicine with its cost-efficient, internationally-certified and ...
Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...
Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...
Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...
During the review, Dr. Singh lauded the Department of Biotechnology and BIRAC for their consistent contributions to medical ...
The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...
Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of therapy. Upon FDA approval of an IND application, Siren plans to start on ...
GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...